{
  "QNTM": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-04T12:07:03Z",
      "headline": "Quantum BioPharma Completes Crossover Design Clinical Trial Of Its unbuzzd Dietary Supplement; Says Results Show unbuzzd Accelerated The Rate At Which Blood Alcohol Concentration Was Reduced In Study Subjects",
      "id": 43458358,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "QNTM"
      ],
      "updated_at": "2025-02-04T12:07:03Z",
      "url": "https://www.benzinga.com/news/25/02/43458358/quantum-biopharma-completes-crossover-design-clinical-trial-of-its-unbuzzd-dietary-supplement-says-r",
      "added_at": "2025-02-04T12:07:15.008Z"
    },
    {
      "author": "Adam Eckert",
      "content": "",
      "created_at": "2025-02-04T14:28:38Z",
      "headline": "Quantum BioPharma Stock Is Soaring Tuesday: What's Driving The Action?",
      "id": 43463656,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2025/02/04/benzingaai2023-modern-computer-screen-wi.png"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2025/02/04/benzingaai2023-modern-computer-screen-wi.png"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2025/02/04/benzingaai2023-modern-computer-screen-wi.png"
        }
      ],
      "source": "benzinga",
      "summary": "Quantum BioPharma Ltd (NASDAQ:QNTM) shares are rising Tuesday after the company announced positive clinical trial results for its unbuzzd dietary supplement.",
      "symbols": [
        "QNTM"
      ],
      "updated_at": "2025-02-04T14:28:38Z",
      "url": "https://www.benzinga.com/trading-ideas/movers/25/02/43463656/quantum-biopharma-stock-is-soaring-tuesday-whats-driving-the-action",
      "added_at": "2025-02-04T14:32:08.492Z"
    }
  ],
  "ACON": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-04T12:28:39Z",
      "headline": "Aclarion Secures Funding For Its CLARITY Trial For Nociscan",
      "id": 43459083,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "ACON"
      ],
      "updated_at": "2025-02-04T12:28:40Z",
      "url": "https://www.benzinga.com/news/25/02/43459083/aclarion-secures-funding-for-its-clarity-trial-for-nociscan",
      "added_at": "2025-02-04T12:32:15.521Z"
    }
  ],
  "CPIX": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-04T12:33:36Z",
      "headline": "Cumberland Pharmaceuticals Announces Advance Results From The Phase 2 FIGHT DMD Trial In Duchenne Muscular Dystrophy Heart Disease",
      "id": 43459313,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "CPIX"
      ],
      "updated_at": "2025-02-04T12:33:37Z",
      "url": "https://www.benzinga.com/general/health-care/25/02/43459313/cumberland-pharmaceuticals-announces-advance-results-from-the-phase-2-fight-dmd-trial-in-duch",
      "added_at": "2025-02-04T12:37:15.526Z"
    },
    {
      "author": "Vandana Singh",
      "content": "",
      "created_at": "2025-02-04T18:31:48Z",
      "headline": "Cumberland Pharmaceuticals' Duchenne Candidate Shows Improved Heart Function In Patients With Associated Heart Disease",
      "id": 43473776,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2025/02/04/CPIX.png"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2025/02/04/CPIX.png"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2025/02/04/CPIX.png"
        }
      ],
      "source": "benzinga",
      "summary": "Cumberland Pharmaceuticals&#39; Phase 2 trial shows ifetroban improves heart function in Duchenne muscular dystrophy patients.",
      "symbols": [
        "CPIX"
      ],
      "updated_at": "2025-02-04T18:31:49Z",
      "url": "https://www.benzinga.com/general/biotech/25/02/43473776/cumberland-pharmaceuticals-duchenne-candidate-shows-improved-heart-function-in-patients-with-associated-heart-disease",
      "added_at": "2025-02-04T18:32:14.187Z"
    }
  ],
  "ZENA": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-04T12:45:35Z",
      "headline": "ZenaTech Inks LOI To Acquire A Fifth Land Survey Company In Southeast Florida",
      "id": 43459511,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "ZENA"
      ],
      "updated_at": "2025-02-04T12:45:36Z",
      "url": "https://www.benzinga.com/m-a/25/02/43459511/zenatech-inks-loi-to-acquire-a-fifth-land-survey-company-in-southeast-florida",
      "added_at": "2025-02-04T12:47:15.714Z"
    }
  ],
  "LAES": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-03T15:03:19Z",
      "headline": "SEALSQ Sees FY25 Confirmed 2025 Bookings $6.4M",
      "id": 43436590,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "LAES"
      ],
      "updated_at": "2025-02-03T15:03:19Z",
      "url": "https://www.benzinga.com/news/25/02/43436590/sealsq-sees-fy25-confirmed-2025-bookings-6-4m",
      "added_at": "2025-02-04T13:00:24.349Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-03T15:02:15Z",
      "headline": "SEALSQ Sees Prelim. FY24 Revenue ~$11M Vs $12.6M Est.",
      "id": 43436530,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "LAES"
      ],
      "updated_at": "2025-02-03T15:02:15Z",
      "url": "https://www.benzinga.com/news/25/02/43436530/sealsq-sees-prelim-fy24-revenue-11m-vs-12-6m-est",
      "added_at": "2025-02-04T13:00:24.349Z"
    }
  ],
  "ENVB": [
    {
      "author": "Vandana Singh",
      "content": "",
      "created_at": "2025-02-04T13:00:27Z",
      "headline": "Enveric Biosciences Inks Two Licensing Agreements With Restoration Biologics To Treat Joint Disease",
      "id": 43460137,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2025/02/04/ENVB.png"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2025/02/04/ENVB.png"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2025/02/04/ENVB.png"
        }
      ],
      "source": "benzinga",
      "summary": "Enveric&#39;s Akos Biosciences licensed its cannabinoid-COX-2 conjugate technology to Restoration Biologics for joint disease treatments, including osteoarthritis.",
      "symbols": [
        "ENVB"
      ],
      "updated_at": "2025-02-04T13:00:28Z",
      "url": "https://www.benzinga.com/general/biotech/25/02/43460137/enveric-biosciences-inks-two-licensing-agreements-with-restoration-biologics-to-treat-joint-disease",
      "added_at": "2025-02-04T13:02:40.054Z"
    }
  ],
  "ELAB": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-04T13:07:04Z",
      "headline": "Northstrive Preparing For Q2 2025 FDA Type B Pre-IND Meeting; Seeks U.S. cGMP Manufacturing Partner For EL-22",
      "id": 43460337,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "ELAB"
      ],
      "updated_at": "2025-02-04T13:07:04Z",
      "url": "https://www.benzinga.com/general/biotech/25/02/43460337/northstrive-preparing-for-q2-2025-fda-type-b-pre-ind-meeting-seeks-u-s-cgmp-manufacturing-partner",
      "added_at": "2025-02-04T13:07:16.133Z"
    }
  ],
  "AMPG": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-04T13:31:52Z",
      "headline": "AmpliTech Group's AmpliTech Inc. Division Receives Additional Purchase Orders Under 5-Year Basic Order Agreement; Says This Increases Cumulative Purchase Orders To Over $1M In Q1 To Date",
      "id": 43461327,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "AMPG"
      ],
      "updated_at": "2025-02-04T13:31:53Z",
      "url": "https://www.benzinga.com/news/25/02/43461327/amplitech-groups-amplitech-inc-division-receives-additional-purchase-orders-under-5-year-basic-order",
      "added_at": "2025-02-04T13:32:16.514Z"
    }
  ],
  "BNRG": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-04T13:35:12Z",
      "headline": "Brenmiller Energy Announces Next-Gen bGen ZERO Thermal Oil System Launch In 2026; Aims To Decarbonize Industrial Thermal Oil Heating With Low-Carbon Heat At Price Parity; Multiple Projects In Negotiation.",
      "id": 43461439,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "BNRG"
      ],
      "updated_at": "2025-02-04T13:35:13Z",
      "url": "https://www.benzinga.com/news/25/02/43461439/brenmiller-energy-announces-next-gen-bgen-zero-thermal-oil-system-launch-in-2026-aims-to-decarbonize",
      "added_at": "2025-02-04T13:37:16.835Z"
    }
  ],
  "JG": [
    {
      "author": "Benzinga Insights",
      "content": "",
      "created_at": "2025-02-03T19:45:20Z",
      "headline": "Peering Into Aurora Mobile's Recent Short Interest",
      "id": 43446606,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2023/movers_image_18.jpeg"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/movers_image_18.jpeg"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2023/movers_image_18.jpeg"
        }
      ],
      "source": "benzinga",
      "summary": " ",
      "symbols": [
        "JG"
      ],
      "updated_at": "2025-02-03T19:45:20Z",
      "url": "https://www.benzinga.com/insights/short-sellers/25/02/43446606/peering-into-aurora-mobiles-recent-short-interest",
      "added_at": "2025-02-04T13:38:34.582Z"
    }
  ],
  "CMND": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-04T13:38:21Z",
      "headline": "Clearmind Medicine Publishes Patent For Binge Behavior Psychedelic Combination Treatment In Mexico",
      "id": 43461584,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "CMND"
      ],
      "updated_at": "2025-02-04T13:38:21Z",
      "url": "https://www.benzinga.com/news/25/02/43461584/clearmind-medicine-publishes-patent-for-binge-behavior-psychedelic-combination-treatment-in-mexico",
      "added_at": "2025-02-04T13:42:17.307Z"
    }
  ],
  "VLCN": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-04T13:34:02Z",
      "headline": "Volcon Becomes Exclusive U.S. Distributor Of Super Sonic Golf Carts",
      "id": 43461410,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "VLCN"
      ],
      "updated_at": "2025-02-04T13:34:03Z",
      "url": "https://www.benzinga.com/news/25/02/43461410/volcon-becomes-exclusive-u-s-distributor-of-super-sonic-golf-carts",
      "added_at": "2025-02-04T13:43:48.335Z"
    }
  ],
  "MNTS": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-04T13:48:14Z",
      "headline": "Momentus Announces Selection By US Air Force's AFWERX For In-Space Demonstration Of Low-Cost Multi-Spectral RPO Sensors; Contract Negotiations Ongoing; Flight Set For Early 2026 On SpaceX Launch",
      "id": 43461791,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "MNTS"
      ],
      "updated_at": "2025-02-04T13:48:15Z",
      "url": "https://www.benzinga.com/news/25/02/43461791/momentus-announces-selection-by-us-air-forces-afwerx-for-in-space-demonstration-of-low-cost-multi-sp",
      "added_at": "2025-02-04T13:52:17.567Z"
    }
  ],
  "SGD": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-04T14:11:29Z",
      "headline": "Safe and Green Development Corporation's LV Peninsula Holding Enters Agreement For Sale Of A Property At Purchase Price Of $6.575M",
      "id": 43462943,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "SGD"
      ],
      "updated_at": "2025-02-04T14:11:30Z",
      "url": "https://www.benzinga.com/news/25/02/43462943/safe-and-green-development-corporations-lv-peninsula-holding-enters-agreement-for-sale-of-a-property",
      "added_at": "2025-02-04T14:12:17.513Z"
    }
  ],
  "KITT": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-03T22:38:55Z",
      "headline": "Nauticus Robotics Reports Assembly Completion Of Its Second Flagship Underwater Vehicle, Aquanaut Mark 2; Targets Completion Of All Acceptance Testing For This Vehicle Within Q1 Of 2025",
      "id": 43450935,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "KITT"
      ],
      "updated_at": "2025-02-03T22:38:56Z",
      "url": "https://www.benzinga.com/news/25/02/43450935/nauticus-robotics-reports-assembly-completion-of-its-second-flagship-underwater-vehicle-aquanaut-mar",
      "added_at": "2025-02-04T14:42:08.495Z"
    }
  ],
  "BKSY": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-04T13:33:11Z",
      "headline": "BlackSky Wins EMDYN Subscription Contract To Deliver On-Demand Gen-2 Space-Based Imagery Services To International Government Customers; Terms Not Disclosed",
      "id": 43461405,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "BKSY"
      ],
      "updated_at": "2025-02-04T13:33:11Z",
      "url": "https://www.benzinga.com/news/25/02/43461405/blacksky-wins-emdyn-subscription-contract-to-deliver-on-demand-gen-2-space-based-imagery-services-to",
      "added_at": "2025-02-04T14:55:04.886Z"
    }
  ],
  "EVAX": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-02-04T16:19:53Z",
      "headline": "Lake Street Maintains Buy on Evaxion Biotech, Lowers Price Target to $6",
      "id": 43469182,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "EVAX"
      ],
      "updated_at": "2025-02-04T16:19:53Z",
      "url": "https://www.benzinga.com/news/25/02/43469182/lake-street-maintains-buy-on-evaxion-biotech-lowers-price-target-to-6",
      "added_at": "2025-02-04T16:22:19.912Z"
    }
  ],
  "AMOD": []
}